{"id":167034,"date":"2025-09-02T07:39:00","date_gmt":"2025-09-02T05:39:00","guid":{"rendered":"https:\/\/renewable-carbon.eu\/news\/?p=167034"},"modified":"2025-08-28T15:11:11","modified_gmt":"2025-08-28T13:11:11","slug":"corbion-and-brain-biotech-team-to-shape-the-future-of-innovation-in-nature-based-ingredient-technologies","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/corbion-and-brain-biotech-team-to-shape-the-future-of-innovation-in-nature-based-ingredient-technologies\/","title":{"rendered":"Corbion and BRAIN Biotech team to shape the future of innovation in nature-based ingredient technologies"},"content":{"rendered":"\n\n
\n
\"\"<\/figure><\/div>\n\n\n

Corbion, the global sustainable ingredients company based in Amsterdam, the Netherlands, and BRAIN Biotech AG, headquartered in Zwingenberg, Germany, have reached agreement to collaborate in the development of novel biobased antimicrobial compounds and its derivatives. This collaboration will accelerate Corbion\u2019s efforts to deliver enabling preservation capabilities to food manufacturers that also resonate with consumers looking for food products based on natural ingredients.<\/strong><\/p>\n\n\n\n

\n

\u201cAt Corbion, advancing the state of the art in nature-based ingredient technologies, proving and expanding on their value and efficacy, is essential to preserving what matters,\u201d said Domenico Vulcano<\/strong>, Vice President of Global Innovation at Corbion<\/strong>. \u201cOne of the ways we continue to strengthen our investment in innovation is through establishing partnerships with other experts like those at BRAIN Biotech. We believe this kind of collaboration will help us bring the next paradigm-changing breakthroughs to market sooner.\u201d<\/p>\n<\/blockquote>\n\n\n\n

BRAIN Biotech AG brings to the collaboration expertise in specialty enzyme technology, microbial strain development, and bioprocess development. Additionally, it operates as a technology licensing company. Corbion brings advanced knowledge of food systems and biobased preservation technologies, intimate customer and industry-specific insights, and leading-edge piloting and scale-up capabilities.<\/p>\n\n\n\n

\n

\u201cWe are very pleased to partner with Corbion in expanding what\u2019s possible with sustainable, bio-based solutions,\u201d said Dr. Martin Langer<\/strong>, Managing Director & Executive Vice President at BRAIN Biotech AG<\/strong>. \u201cWe see a very strong affinity between our team at BRAIN and our collaborators at Corbion. Given our respective strengths, shared vision, and complementary areas of expertise, we expect this to be a fruitful collaboration that will deliver real impact for the world\u2019s food manufacturers.\u201d<\/p>\n<\/blockquote>\n\n\n\n

<\/div>\n\n\n\n

About Corbion<\/h3>\n\n\n\n

Corbion is a sustainable ingredients company dedicated to preserving what matters, including food and food production, health, and the planet. We specialize in lactic acid, lactic acid derivatives, food preservation solutions, functional blends, and algae ingredients, using our deep application and product knowledge to propel nature\u2019s ingenuity through science. With more than a century of experience, we continue working side by-side with our customers to make our cutting-edge technologies work for them. Leveraging our advanced capabilities in fermentation and preservation technology, we help customers differentiate their products in diverse markets ranging from food and animal nutrition to home & personal care, pharmaceuticals, electronics, medical devices, and bioplastics. In 2024, Corbion generated annual sales of \u20ac 1,332.0 million with a workforce of 2,399 FTEs. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com<\/a><\/p>\n\n\n\n

<\/p>\n\n\n\n

About BRAIN Biotech<\/h3>\n\n\n\n

The BRAIN Biotech Group is a leader in researching, developing, and producing specialty enzymes, focusing on the food and life sciences industries. In addition, the group develops microbial production strains and scalable bioprocesses for the economic production of specialty enzymes and other proteins. BRAIN Biotech also offers customized biological solutions to the industry for more sustainable products and efficient processes. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The company\u00b4s activities are divided into two business segments: BRAINBiocatalysts (development, production, and distribution of specialty enzymes, microorganisms, and ingredients) and BRAINBioIncubator (research-intensive development projects and pharmaceuticals). BRAIN Biotech operates its own fermentation facilities in the UK and has additional production sites in continental Europe and the US. BRAIN Biotech AG has been listed on the Frankfurt Stock Exchange since February 9, 2016 (Ticker symbol: BNN; ISIN: DE0005203947 \/ WKN: 520394). In the 2023\/24 fiscal year, the group generated revenue of \u20ac54.6 million with around 300 employees. For more information, visit: www.brain-biotech-group.com.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Corbion, the global sustainable ingredients company based in Amsterdam, the Netherlands, and BRAIN Biotech AG, headquartered in Zwingenberg, Germany, have reached agreement to collaborate in the development of novel biobased antimicrobial compounds and its derivatives. This collaboration will accelerate Corbion\u2019s efforts to deliver enabling preservation capabilities to food manufacturers that also resonate with consumers looking […]<\/p>\n","protected":false},"author":59,"featured_media":167060,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","nova_meta_subtitle":"Together, the partners will develop preservation capabilities to food manufacturers that also resonate with consumers looking for food products based on natural ingredients","footnotes":""},"categories":[5572],"tags":[6843,5838,5796,5840,21927],"supplier":[736,5384],"class_list":["post-167034","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-based","tag-biochemicals","tag-bioeconomy","tag-biotechnology","tag-enzymes","tag-mikrobes","supplier-brain-ag-biotechnology-research-and-information-network-ag","supplier-corbion"],"_links":{"self":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/167034","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/users\/59"}],"replies":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/comments?post=167034"}],"version-history":[{"count":0,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/posts\/167034\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media\/167060"}],"wp:attachment":[{"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/media?parent=167034"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/categories?post=167034"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/tags?post=167034"},{"taxonomy":"supplier","embeddable":true,"href":"https:\/\/renewable-carbon.eu\/news\/wp-json\/wp\/v2\/supplier?post=167034"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}